Literature DB >> 22818027

Regulation of collateral blood vessel development by the innate and adaptive immune system.

Andrea la Sala1, Laura Pontecorvo, Alessia Agresta, Giuseppe Rosano, Eugenio Stabile.   

Abstract

The development of collateral circulation is an inherent compensatory mechanism to restore impaired blood perfusion following artery stenosis and/or occlusion. This process, termed arteriogenesis, is driven by inflammation and involves a complex remodeling of pre-existing conduit vessels running in parallel to the occluded artery. Recent studies have unveiled roles for different immune cell subsets as regulators of arteriogenesis, including natural killer (NK) cells, T helper 17 (Th17) cells, regulatory T lymphocytes (Tregs), and functional subsets of macrophages (e.g., M2 macrophages). This review summarizes recent findings and discusses future research needed to better define the time during which each cellular subset is active and reveal further critical regulatory switches.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22818027     DOI: 10.1016/j.molmed.2012.06.007

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  26 in total

Review 1.  Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials.

Authors:  Jialing Liu; Yongting Wang; Yosuke Akamatsu; Chih Cheng Lee; R Anne Stetler; Michael T Lawton; Guo-Yuan Yang
Journal:  Prog Neurobiol       Date:  2013-11-27       Impact factor: 11.685

2.  Polymerase δ-interacting protein 2 promotes postischemic neovascularization of the mouse hindlimb.

Authors:  Angélica M Amanso; Bernard Lassègue; Giji Joseph; Natalia Landázuri; James S Long; Daiana Weiss; W Robert Taylor; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-22       Impact factor: 8.311

Review 3.  Collaterals: Implications in cerebral ischemic diseases and therapeutic interventions.

Authors:  Yasuo Nishijima; Yosuke Akamatsu; Phillip R Weinstein; Jialing Liu
Journal:  Brain Res       Date:  2015-03-11       Impact factor: 3.252

Review 4.  Manipulating the intersection of angiogenesis and inflammation.

Authors:  Brian J Kwee; David J Mooney
Journal:  Ann Biomed Eng       Date:  2014-10-15       Impact factor: 3.934

5.  A MicroRNA93-Interferon Regulatory Factor-9-Immunoresponsive Gene-1-Itaconic Acid Pathway Modulates M2-Like Macrophage Polarization to Revascularize Ischemic Muscle.

Authors:  Vijay Chaitanya Ganta; Min Hyub Choi; Anna Kutateladze; Todd E Fox; Charles R Farber; Brian H Annex
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

6.  Lower Arterial Cross-Sectional Area of Carotid and Vertebral Arteries and Higher Frequency of Secondary Neck Vessels Are Associated with Multiple Sclerosis.

Authors:  P Belov; D Jakimovski; J Krawiecki; C Magnano; J Hagemeier; L Pelizzari; B Weinstock-Guttman; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2017-12-07       Impact factor: 3.825

7.  AMP-Activated Protein Kinase α1 in Macrophages Promotes Collateral Remodeling and Arteriogenesis in Mice In Vivo.

Authors:  Huaiping Zhu; Miao Zhang; Zhaoyu Liu; Junjie Xing; Cate Moriasi; Xiaoyan Dai; Ming-Hui Zou
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-21       Impact factor: 8.311

8.  Temporal remodeling of pial collaterals and functional deficits in a murine model of ischemic stroke.

Authors:  Benjamin Okyere; Miranda Creasey; Yeonwoo Lebovitz; Michelle H Theus
Journal:  J Neurosci Methods       Date:  2017-09-18       Impact factor: 2.390

Review 9.  Macrophage Polarization in Response to Biomaterials for Vascularization.

Authors:  Yuqing Wang; Yubo Fan; Haifeng Liu
Journal:  Ann Biomed Eng       Date:  2021-07-19       Impact factor: 3.934

10.  Endothelial β1 Integrin-Mediated Adaptation to Myocardial Ischemia.

Authors:  Carina Henning; Anna Branopolski; Paula Follert; Oksana Lewandowska; Aysel Ayhan; Marcel Benkhoff; Ulrich Flögel; Malte Kelm; Christian Heiss; Eckhard Lammert
Journal:  Thromb Haemost       Date:  2021-01-14       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.